Which has grown faster, DGX or MRNA?

Over the past five years, MRNA grew revenue faster — DGX at a 0.89% CAGR versus MRNA at 19.33%.

Does DGX or MRNA pay a bigger dividend?

DGX pays a dividend (1.39% yield), while MRNA has no payments in the available dividend history.

Is DGX or MRNA more profitable?

DGX runs the higher net margin — DGX at 9.19% versus MRNA at -141.43%.

How have DGX and MRNA total returns compared?

Over the past 5 years, DGX delivered 12.97% and MRNA delivered -32.21% annualized total return. Past performance doesn't predict future results.

Quest Diagnostics Incorporated (DGX) vs Moderna, Inc. (MRNA)

A side-by-side comparison of Quest Diagnostics Incorporated and Moderna, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 10, 2026. Differences are shown without an overall score or investment verdict.

DGX

Quest Diagnostics Incorporated

$26.23B

$237.62HealthcareDelayed quote: Aug 10, 2026, 1:20 PM EDT

MRNA

Moderna, Inc.

$23.66B

$59.64HealthcareDelayed quote: Aug 10, 2026, 1:15 PM EDT

Total return — DGX vs MRNA

growth of $100 · dividends reinvested · last 8y

DGX +210.2% (+15.2%/yr)MRNA +218.1% (+15.6%/yr)MRNA compounded faster over this window

DGX MRNA

DGX vs MRNA: by the numbers

•DGX is the larger company ($26.23B vs $23.66B market cap).
•DGX is profitable (9.19% net margin) while MRNA runs a net loss (-141.43%).
•MRNA grew revenue faster over the past five years (19.33% vs 0.89% CAGR).
•DGX pays a dividend (1.39% yield), while MRNA has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	DGX	MRNA
P/E ratio	25.30	N/A
Forward P/E	21.30	N/A
P/S ratio	2.31	10.52
P/B ratio	3.55	3.47
EV / EBITDA	16.25	N/A
FCF yield	4.57%	N/A

Profitability

Metric	DGX	MRNA
Gross margin	33.15%	55.35%
Operating margin	14.14%	-158.13%
Net margin	9.19%	-141.43%
ROE	14.13%	-46.61%
ROIC	8.43%	-29.70%

Dividends

Metric	DGX	MRNA
Dividend yield	1.39%	N/A
Payout ratio	37.43%	N/A

Growth (annualized)

Metric	DGX	MRNA
Revenue CAGR (5Y)	0.89%	19.33%
EPS CAGR (5Y)	-3.65%	N/A
FCF CAGR (5Y)	-10.89%	N/A
Total return CAGR (5Y)	12.37%	-32.21%

Frequently asked

Which has grown faster, DGX or MRNA?: Over the past five years, MRNA grew revenue faster — DGX at a 0.89% CAGR versus MRNA at 19.33%.
Does DGX or MRNA pay a bigger dividend?: DGX pays a dividend (1.39% yield), while MRNA has no payments in the available dividend history.
Is DGX or MRNA more profitable?: DGX runs the higher net margin — DGX at 9.19% versus MRNA at -141.43%.
How have DGX and MRNA total returns compared?: Over the past 5 years, DGX delivered 12.97% and MRNA delivered -32.21% annualized total return. Past performance doesn't predict future results.

Go deeper

Full DGX analysis Full MRNA analysis Interactive comparison tool

Dig into the metrics

Quest Diagnostics P/E ratio Quest Diagnostics dividend yield Quest Diagnostics ROE Moderna ROE Quest Diagnostics operating margin Moderna operating margin Quest Diagnostics revenue growth Moderna revenue growth Quest Diagnostics free cash flow Moderna free cash flow

Quest Diagnostics & Moderna appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 10, 2026.